These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23940389)

  • 1. Management of patients after endovascular interventions for peripheral artery disease.
    Sobieszczyk P; Eisenhauer A
    Circulation; 2013 Aug; 128(7):749-57. PubMed ID: 23940389
    [No Abstract]   [Full Text] [Related]  

  • 2. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
    J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.
    Iida O; Yokoi H; Soga Y; Inoue N; Suzuki K; Yokoi Y; Kawasaki D; Zen K; Urasawa K; Shintani Y; Miyamoto A; Hirano K; Miyashita Y; Tsuchiya T; Shinozaki N; Nakamura M; Isshiki T; Hamasaki T; Nanto S;
    Circulation; 2013 Jun; 127(23):2307-15. PubMed ID: 23652861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
    Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting.
    Hayes DJ; Dougherty MJ; Calligaro KD
    Ann Vasc Surg; 2011 May; 25(4):559.e19-23. PubMed ID: 21549939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twelve-month experience with the GORE® TIGRIS® Vascular Stent in the superficial femoral and popliteal arteries.
    Piorkowski M; Freitas B; Steiner S; Botsios S; Bausback Y; Scheinert D; Schmidt A
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):89-95. PubMed ID: 25410147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of antithrombotic therapy and the rationale and design of the randomized edoxaban in patients with peripheral artery disease (ePAD) trial adding edoxaban or clopidogrel to aspirin after femoropopliteal endovascular intervention.
    Tangelder MJ; Nwachuku CE; Jaff M; Baumgartner I; Duggal A; Adams G; Ansel G; Grosso M; Mercuri M; Shi M; Minar E; Moll FL
    J Endovasc Ther; 2015 Apr; 22(2):261-8. PubMed ID: 25809373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study.
    George JC; Rosen ES; Nachtigall J; VanHise A; Kovach R
    J Vasc Interv Radiol; 2014 Jun; 25(6):954-61. PubMed ID: 24768325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of sarpogrelate after endovascular treatment for femoropopliteal artery disease: ESPALIER study.
    Soga Y; Shintani Y; Hamasaki T; Tomoi Y; Takaoka J; Suematsu N; Yokoi H; Ando K;
    Cardiovasc Interv Ther; 2017 Oct; 32(4):325-332. PubMed ID: 27456034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease.
    Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S
    JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
    Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
    J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases.
    Ascher E; Marks NA; Hingorani AP; Schutzer RW; Mutyala M
    J Vasc Surg; 2006 Dec; 44(6):1230-7; discussion 1237-8. PubMed ID: 17055689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.
    Grenville JL; Tan KT; Moshonov H; Rajan DK
    Vascular; 2015 Feb; 23(1):31-40. PubMed ID: 24695358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrograde popliteal approach for challenging occlusions of the femoral-popliteal arteries.
    Ye M; Zhang H; Huang X; Shi Y; Yao Q; Zhang L; Zhang J
    J Vasc Surg; 2013 Jul; 58(1):84-9. PubMed ID: 23806253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery.
    Lensvelt MM; Wikkeling OR; Van Oostayen JA; Roukema JG; Zeebregts CJ; Reijnen MM
    Vasc Endovascular Surg; 2012 May; 46(4):338-41. PubMed ID: 22504512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: a randomized controlled trial.
    Koppensteiner R; Spring S; Amann-Vesti BR; Meier T; Pfammatter T; Rousson V; Banyai M; van der Loo B
    J Vasc Surg; 2006 Dec; 44(6):1247-53. PubMed ID: 17145426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
    Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
    J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and narrative synthesis of surveillance practices after endovascular intervention for lower limb peripheral arterial disease.
    Wong KHF; Zucker BE; Wardle BG; Coughlin PA; Chaplin K; Cheng HY; Hinchliffe RJ; Twine CP; Ambler GK
    J Vasc Surg; 2022 Jan; 75(1):372-380.e15. PubMed ID: 34506892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents?
    Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.